Proton Therapy Patient Registry
1 other identifier
observational
999
1 country
1
Brief Summary
The purpose of this study is to establish a database (or "registry") of patients treated with proton beam therapy at the University Hospitals (UH) Proton Therapy Center. By keeping track of the patients treated it will allow the investigators to periodically evaluate the outcomes of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 22, 2016
CompletedFirst Submitted
Initial submission to the registry
December 6, 2016
CompletedFirst Posted
Study publicly available on registry
December 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 9, 2026
April 1, 2026
11 years
December 6, 2016
April 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants treated at UH Proton Therapy Center by proton beam therapy
Up to 10 years
Study Arms (1)
Proton Beam Therapy
All patients treated with proton beam therapy at the UH Proton Therapy Center who consent to have their health information recorded, including whether the cancer was cured and if any complications occur ed due to treatment
Interventions
Intervention is not assigned. Only patient data is being collected
Eligibility Criteria
All patients treated with proton beam at the UH Proton Therapy Center
You may qualify if:
- Patients treated with proton beam at the UH Proton Therapy Center
- Patients who have the ability to understand and be willing to sign a written informed consent document
You may not qualify if:
- Patients or legal guardians who are unable to understand informed consent document
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David B Mansur, MD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2016
First Posted
December 8, 2016
Study Start
November 22, 2016
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 9, 2026
Record last verified: 2026-04